title: Vascular eicosanoids and platelet-aortic wall interactions in spontaneously hypertensive rats.
abstract: We studied the aggregation of collagen and ADP-stimulated platelet-rich plasma (PRP) and the formation of thromboxane B2 (TxB2) by collagen-stimulated PRP in spontaneously hypertensive rats (SHR) and in Wistar-Kyoto control rats (WKY). In addition, we evaluated the inhibition of the aggregation of PRP following homologous or heterologous perfusions through isolated aortas, the release of 6-keto-prostaglandin (PG)F1 alpha from these arteries perfused with PRP, and the sensitivity of PRP to the antiaggregatory activity of the stable PGI2 analogue, iloprost, in both SHR and WKY. The lower activities (aggregation induced by ADP and collagen, collagen-stimulated TxB2 production) of SHR platelets, were not accompanied by morphological differences from WKY platelets. These changes were associated with a greater release of arterial 6-keto-PGF1 alpha, with greater platelet antiaggregatory activity of the arterial wall and with higher sensitivity of platelets to iloprost. The lower reactivity of platelets to aggregating agents, and the greater sensitivity to prostacyclin, associated with a greater production of arterial prostacyclin were the major changes observed in SHR animals. These alterations in the SHR vs. normotensive WKY may lead to an enhanced risk of hemorrhage in the hypertensive state.
authors.affiliation: Pharmaco-Biological Department, University of Bari, Italy.
authors.forename: M D
authors.initials: MD
authors.lastname: Lograno
authors.forename: C
authors.initials: C
authors.lastname: Mosconi
authors.forename: F
authors.initials: F
authors.lastname: Marangoni
authors.forename: L
authors.initials: L
authors.lastname: Medini
authors.forename: G
authors.initials: G
authors.lastname: Grassi
authors.forename: C
authors.initials: C
authors.lastname: Galli
mesh_terms: D015121:6-Ketoprostaglandin F1 alpha / Q000097:blood*; D000244:Adenosine Diphosphate / Q000494:pharmacology; D000818:Animals; D001011:Aorta; D001792:Blood Platelets / Q000378:metabolism* / Q000648:ultrastructure; D003094:Collagen / Q000494:pharmacology; D006973:Hypertension / Q000097:blood*; D016285:Iloprost / Q000494:pharmacology; D008297:Male; D010477:Perfusion; D010974:Platelet Aggregation / Q000187:drug effects; D051381:Rats; D011918:Rats, Inbred SHR; D011921:Rats, Inbred WKY; D013929:Thromboxane B2 / Q000097:blood*
chemical_list: D013929:Thromboxane B2; D015121:6-Ketoprostaglandin F1 alpha; D000244:Adenosine Diphosphate; D003094:Collagen; D016285:Iloprost